News

Pharmabiz21m
Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader
Ensem Therapeutics doses first patient in phase 1/2 clinical study of ETX-636, a novel allosteric pan-mutant-selective PI3Ka inhibitor and degrader: Waltham, Massachusetts Saturda ...
Pharmabiz1h
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome
Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...
Pharmabiz2h
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use: Eindhoven, the Netherlands Saturday, July ...
Pharmabiz2h
Kairali Ayurvedic Group opens first Ayurveda wellness centre in Jaipur
Kairali Ayurvedic Group opens first Ayurveda wellness centre in Jaipur: Our Bureau, Mumbai Saturday, July 5, 2025, 11:30 Hrs [IST] Kairali Ayurvedic Group, one of India’s most t ...
Pharmabiz3h
InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China
InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China: Beijing Saturday, July 5, 2025, 11:00 Hrs [IST] InnoCare Pharma, a commercial ...
Pharmabiz4h
HanchorBio inks licensing pact with Shanghai Henlius Biotech to develop & commercialise HCB101 across Greater China
HanchorBio inks licensing pact with Shanghai Henlius Biotech to develop & commercialise HCB101 across Greater China: Taipei, Shanghai Saturday, July 5, 2025, 10:00 Hrs [IST] Hanch ...
Pharmabiz5h
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...
Pharmabiz6h
ICMR-NIREH to host workshop on ddPCR from August 11 to 14 with special emphasis on molecular virology
Shardul Nautiyal, Mumbai Saturday, July 5, 2025, 08:00 Hrs [IST] ...
Pharmabiz6h
Pharma export continues its growth trajectory with USD 2,475.70 million in May 2025
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has reported that India's pharmaceutical export continued its growth trajectory with USD 2,475.70 million in May 2025, cumulating to ...
Pharmabiz6h
Indian healthcare sector grapples with acute shortages of infrastructure & skilled professionals: Dr Raj Nagarkar
Indian healthcare sector grapples with acute shortages of infrastructure & skilled professionals: Dr Raj Nagarkar: Nandita Vijayasimha, Bengaluru Saturday, July 5, 2025, 08:00 Hrs ...
Pharmabiz6h
DCC recommends DCGI to share SOPs and formats with States as per IDP
DCC recommends DCGI to share SOPs and formats with States as per IDP: Gireesh Babu, New Delhi Saturday, July 5, 2025, 08:00 Hrs [IST] The Drugs Consultative Committee (DCC) has re ...
Pharmabiz6h
Govt support fuels Indian pharma growth amidst challenges: T Revichandran
The Union government's substantial and commendable support for the Indian pharmaceutical industry, particularly for the MSME sector, is evident. T. Revichandran, vice-president of IDMA South Region, ...